Navigation Links
Express Scripts Reports Third Quarter 2013 Results
Date:10/24/2013

tion of intangible assets (9)

$1.50Transaction, integration and other non-recurring costs(10)

 To be determined *The full-year impact of transaction, integration and other non-recurring costs have yet to be determined. Accordingly, the Company is unable to include these charges in the list of GAAP items not included in guidance for 2013 revised adjusted EPS from continuing operations or to provide a reconciliation to the corresponding GAAP measure. ** Selling, general and administrative expense is expected to decline approximately 8% from $2,338.2 million on an adjusted basis in 2012 (as recast for discontinued operations).*** Due to delays in certain non-client integration activities, including the migration of Medco's legacy payment cycles to Express Scripts' cycles, the Company has adjusted its 2013 cash flow guidance range to $4.0 billion to $4.5 billion from the previous range of $4.5 billion to $5.0 billion. Note: See Appendix for Footnotes  

  Appendix  Footnotes (1) Includes home delivery, specialty and other including:  (a) drugs distributed through patient assistance programs (b) drugs we distribute to other PBMs' clients under limited distribution contracts with pharmaceutical manufacturers and (c) FreedomFP claims. (2) Total adjusted claims reflect home delivery claims multiplied by 3, as home delivery claims typically cover a time period 3 times longer than retail claims. (3) Amortization of intangible assets includes the following items:
Amortization of legacy Express Scripts intangible assets include amounts in both revenues and selling, general and administrative expense.
Revenue amortization is related to the customer contract with WellPoint which consummated upon closing of the NextRx acquisition in 2009.  Under U.S. GAAP standards, amortization of intangibles that a
'/>"/>

SOURCE Express Scripts Holding Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Ventana receives approval from Chinas FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients
2. Express Scripts Acquires SmartD Medicare Prescription Drug Plan; Adds to Industry-Leading Medicare Offering
3. Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board
4. Express Scripts To Discuss Outlook for Future Growth
5. Suture Express Announces New Board Chairman
6. Patients and Physicians Express Desire to Switch to Transdermal Drug Delivery, Finds Frost & Sullivan
7. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
8. Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
9. Express Scripts Reports First Quarter 2013 Results
10. Bipartisan Group of 124 Lawmakers Express Concern That Medicare Cuts to Life-Sustaining Cancer Drugs Threatening Patient Care
11. Express Scripts Holding Company Announces First Quarter 2013 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Calif. , Aug. 28, 2014  STAAR Surgical Company ... marketer of implantable lenses and delivery systems for the eye, ... Health Care Conference at the New York Palace Hotel on ... Barry Caldwell , President and CEO will offer ... results, and operational developments and be joined by Steve ...
(Date:8/27/2014)... 2014 TWi Pharmaceuticals, Inc. (4180.TT) today announced ... United States Food and Drug Administration (FDA) on ... acetate 125mg/ml oral suspension, the generic equivalent to ... and under Hatch Waxman rules, it will be ... has completed the pre-launch preparation of the generic ...
(Date:8/27/2014)... Va. , Aug. 27, 2014 About ... the legs due to buildup of fatty plaque in ... in the aging patient population and in incidences of ... offers its Lower Extremity Arterial RevascularizatioN (LEARN) ... Endovascular specialists and interested residents and fellows ...
Breaking Medicine Technology:STAAR Surgical To Present At The Baird 2014 Health Care Conference 2TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3
... 11, 2010 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE Amex: ... leading fully-integrated specialty pharmaceuticals company in China, today announced financial ... ThirdQ uarter Highlights ... the third quarter of fiscal year 2009 Excluding an ...
... BOSTON, November 11, 2010 ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
Cached Medicine Technology:China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 2China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 3China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 4China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 5China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 6China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 7China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 8China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 9EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 2EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 3EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 4EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 5EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 6EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 7EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 8
(Date:8/28/2014)... researchers place glue directly on the nerve stumps, but ... and allows glue to easily invade the nerve ends. ... to insert the nerve ends into the conduit because ... Xiangdang Liang and co-workers from the General Hospital of ... technique and defined the best parameters for its use ...
(Date:8/28/2014)... 2014 One in every 200 Ontarians has been ... of people living with the disease increasing by 64 ... study by researchers at the Institute for Clinical Evaluative ... and the Ottawa Hospital Research Institute. That puts Ontario ... world. , The study, published this week in ...
(Date:8/28/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... GLOBAL MARKETS , the global market for surgical navigation ... by the need for replacement of existing installations and ... the market is expected to grow to $631.9 million ... from 2013 through 2018. , While revenue generation will ...
(Date:8/28/2014)... Port Washington, New York (PRWEB) August 28, 2014 ... law firm that has spent many years fighting to ... comments that the decision to provide coverage to WTC ... report released by the U.S. Government Accountability Office (GAO). ... Watch on August 25th, the report is entitled ...
(Date:8/28/2014)... Clarity PSO , an operating division ... federal Patient Safety Organization (PSO) for another three-year period ... and Quality (AHRQ). Clarity PSO will continue to provide ... the true intentions of the Patient Safety and Quality ... and eager to continue our journey as a PSO ...
Breaking Medicine News(10 mins):Health News:Ontario has one of the highest rates of IBD in the world 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3
... Therapeutics Inc. (Nasdaq: CRTX ), a specialty pharmaceutical company focused on ... today reported financial results for the three and six months ended June 30, ... , , Second quarter net revenues increase ... , , , ...
... , MARL, Germany, Aug. 11 Smith & ... SNN ) announced that the German District Court in Dusseldorf decided ... Kinetic Concepts, Inc (NYSE: KCI ) for a Preliminary ... Pressure Wound Therapy (NPWT) pump in Germany based on alleged infringement ...
... ... teeth whitening treatments , ... MN (PRWEB) August 11, 2009 -- Dr. Wilhelm , DMD MSD, announced today he ... Spraywhite , the only spray-on, in-home professional teeth whitening treatment. Made with Aerowhite™, WOW ...
... ... Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. ... (PRWEB) August 11, ... Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. ...
... DALLAS Aug. 11, 2009 People diagnosed with type ... weight, developing low blood sugar and seeing their quality of ... Medical Center suggests that those fears are largely unfounded and ... defense, as opposed to a treatment of last resort for ...
... , , ... Obama,s efforts to position government-funded health care as a "cost-cutter" for ... to reduce health care costs, according to a national survey question ... The majority of respondents believe national tort reform laws ...
Cached Medicine News:Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 2Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 3Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 4Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 5Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 6Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 7Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 8Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 9Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 10Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 11Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 12Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 13Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 14Health News:German District Court Rules in Smith & Nephew's Favor in Patent Infringement Case 2Health News:German District Court Rules in Smith & Nephew's Favor in Patent Infringement Case 3Health News:Dr. Wilhelm, First Minnesota Cosmetic Dentist to Offer WOW Spraywhite Teeth Whitening 2Health News:Dr. Wilhelm, First Minnesota Cosmetic Dentist to Offer WOW Spraywhite Teeth Whitening 3Health News:The Jones Center for Diabetes & Endocrine Wellness Selects Retasure to Enhance Diabetes Care 2Health News:UT Southwestern physicians bust myths about insulin 2Health News:New Poll Shows Two-Thirds of Americans Don't Think Government Health Care Will Cut Costs 2
Designed for simple operation, the Model 515B pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
... The Models 512 and 513 handheld ... This advanced technology is able to ... resolutions and speeds of 100 times ... in improved pulse oximeter performance during ...
... Whether it's for an emergency situation, bedside ... Handheld Capnograph / Pulse Oximeter delivers accurate ... This portable, handheld monitor now contains Nellcors ... compatible with OxiMax sensors. The NPB-75 monitor ...
The new Nellcor N-45 Handheld Pulse Oximeter is compatible with our complete line of OxiMax Pulse Oximetry Sensors, so clinicians have the convenience of Nellcors most advanced sensor technology in a...
Medicine Products: